Medicare Enrolled
Dr. Vijay Patel, MD
Hematology · Gainesville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Vijay Patel is a hematology in Gainesville, FL, with 18 years in practice. Based on federal Medicare data, Dr. Patel performed 507,088 Medicare services across 6,532 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $95,850 from 81 pharmaceutical and/or device companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 1% volume in FL$ $95,850 industry payments
Medicare Practice Summary
Medicare Utilization ↗507,088
Medicare services
Top 1% in FL for hematology
6,532
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~28,172 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 170,850 | $0 | $4 |
| Nivolumab injection (Opdivo) | 51,650 | $24 | $72 |
| Pembrolizumab injection (Keytruda) | 36,200 | $43 | $137 |
| Oxaliplatin chemotherapy injection | 35,158 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 31,980 | $18 | $51 |
| Iron infusion (Injectafer) | 26,250 | $1 | $3 |
| Anti-nausea injection (aprepitant) | 26,130 | $1 | $5 |
| Iron sucrose injection (Venofer) | 24,600 | $0 | $5 |
| Paclitaxel chemotherapy injection | 20,097 | $0 | $2 |
| Injection, degarelix, 1 mg | 10,240 | $3 | $10 |
| Epoetin alfa injection (Procrit) for anemia | 9,800 | $6 | $23 |
| Dexamethasone injection (steroid) | 7,201 | $0 | $3 |
| Iron infusion (Monoferric) | 7,100 | $16 | $57 |
| Filgrastim injection (Zarxio) for white blood cells | 6,780 | $0 | $2 |
| Immune globulin infusion (Gammagard) | 6,636 | $36 | $108 |
| Injection, bortezomib, 0.1 mg | 4,843 | $4 | $113 |
| Injection, eflapegrastim-xnst, 0.1 mg | 4,224 | $26 | $116 |
| Complete blood count (CBC) with differential | 3,403 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,310 | $1 | $28 |
| Blood draw (venipuncture) | 3,227 | $8 | $9 |
| Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 2,649 | $55 | $192 |
| Injection, leucovorin calcium, per 50 mg | 1,600 | $3 | $12 |
| Office visit, established patient (30-39 min) | 1,445 | $96 | $339 |
| Injection, fluorouracil, 500 mg | 989 | $2 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 912 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 907 | $97 | $378 |
| Drug injection, under skin or into muscle | 834 | $10 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 771 | $22 | $84 |
| Injection of additional new drug or substance into vein | 762 | $12 | $61 |
| Injection, carboplatin, 50 mg | 751 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 653 | $47 | $189 |
| Injection, fulvestrant, 25 mg | 520 | $8 | $132 |
| Office visit, established patient (20-29 min) | 482 | $64 | $239 |
| Injection, diphenhydramine hcl, up to 50 mg | 349 | $1 | $3 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 321 | $24 | $89 |
| Administration of additional new drug or substance into vein, 1 hour or less | 318 | $49 | $178 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 272 | $133 | $562 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 265 | $54 | $206 |
| Administration of chemotherapy into vein, each additional hour | 222 | $22 | $79 |
| Infusion into a vein for hydration, each additional hour | 199 | $10 | $42 |
| Administration of additional new drug or substance into vein using push technique | 176 | $42 | $170 |
| Injection, zoledronic acid, 1 mg | 162 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 158 | $15 | $56 |
| Injection, magnesium sulfate, per 500 mg | 156 | $1 | $2 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 154 | $17 | $59 |
| New patient office visit, complex (60-74 min) | 149 | $166 | $585 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 130 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 123 | $2 | $7 |
| Injection of drug or substance into vein | 122 | $27 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 113 | $15 | $56 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 106 | $127 | $637 |
| Initial hospital admission, high complexity | 100 | $137 | $556 |
| Hospital follow-up visit, moderate complexity | 97 | $62 | $197 |
| Automated urinalysis | 82 | $2 | $8 |
| Infusion into a vein for hydration, 31-60 minutes | 80 | $24 | $156 |
| New patient office visit (45-59 min) | 72 | $123 | $453 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 47 | $1 | $7 |
| Red blood count, automated test | 44 | $4 | $10 |
| Office visit, established patient, complex (40-54 min) | 29 | $139 | $474 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 22 | $125 | $467 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 22 | $4 | $15 |
| Transitional care management services for problem of high complexity | 18 | $214 | $722 |
| Office visit, established patient (10-19 min) | 14 | $38 | $147 |
| Transitional care management services for problem of at least moderate complexity | 12 | $158 | $533 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.0% high complexity
56.0% medium
2.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$95,850
Total received (2018-2024)
Avg $13,693/year across 7 years
Top 5% in FL for hematology
81
Companies
350
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$86,389 (90.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,111 (8.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,350 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,256
2023$1,103
2022$10,453
2021$20,906
2020$10,949
2019$27,206
2018$23,978
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$38,181
Bayer HealthCare Pharmaceuticals Inc.
$19,027
Regeneron Healthcare Solutions, Inc.
$17,133
Heron Therapeutics, Inc.
$8,272
GENZYME CORPORATION
$2,337
PFIZER INC.
$1,795
Celgene Corporation
$1,513
Amgen Inc.
$1,085
Alexion Pharmaceuticals, Inc.
$559
AstraZeneca Pharmaceuticals LP
$511
Daiichi Sankyo Inc.
$462
Genentech USA, Inc.
$392
Novartis Pharmaceuticals Corporation
$352
Seagen Inc.
$321
Nutech Spine, Inc.
$280
Janssen Biotech, Inc.
$247
Biohaven Pharmaceuticals, Inc.
$215
Novocure GmbH
$200
Athenex Pharmaceutical Division, LLC
$175
Ipsen Biopharmaceuticals, Inc
$170
Ethicon US, LLC
$149
TESARO, Inc.
$137
Incyte Corporation
$135
Myovant Sciences Inc.
$122
Edwards Lifesciences Corporation
$116
E.R. Squibb & Sons, L.L.C.
$113
Novo Nordisk Inc
$107
Seattle Genetics, Inc.
$96
Gilead Sciences, Inc.
$89
Galvanize Therapeutics, Inc
$84
Spectrum Pharmaceuticals Inc.
$82
PORTOLA PHARMACEUTICALS, INC.
$79
Astellas Pharma US Inc
$61
Genmab U.S., Inc.
$58
GlaxoSmithKline, LLC.
$54
Intuitive Surgical, Inc.
$52
Karyopharm Therapeutics Inc.
$51
SERVIER PHARMACEUTICALS LLC
$50
ABBVIE INC.
$45
G1 Therapeutics, Inc.
$39
Eisai Inc.
$38
SOBI, INC
$38
TerSera Therapeutics LLC
$37
Merck Sharp & Dohme Corporation
$36
BeiGene USA, Inc.
$35
Agios Pharmaceuticals, Inc.
$34
EMD Serono, Inc.
$33
ARRAY BIOPHARMA INC
$33
MEDIVATION FIELD SOLUTIONS LLC
$31
AVEO Pharmaceuticals, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
CTI BioPharma Corp.
$28
Apellis Pharmaceuticals, Inc.
$28
Pharmacyclics LLC, An AbbVie Company
$26
Bayer Healthcare Pharmaceuticals Inc.
$26
PharmaEssentia USA Corporation
$25
Johnson & Johnson Health Care Systems Inc.
$25
Secura Bio, Inc.
$24
Stemline Therapeutics Inc.
$22
Octapharma USA, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
Napo Pharmaceuticals Inc
$19
Rigel Pharmaceuticals, Inc.
$19
Myriad Genetic Laboratories, Inc.
$18
Kite Pharma, Inc.
$17
MorphoSys, US Inc.
$16
Lilly USA, LLC
$16
Aveo Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme LLC
$15
CSL Behring
$15
TAIHO ONCOLOGY, INC.
$14
Global Blood Therapeutics, Inc.
$14
Mirati Therapeutics, Inc.
$14
GE HealthCare
$14
Aurobindo Pharma USA, Inc.
$14
Boston Scientific Corporation
$12
AbbVie, Inc.
$12
NanoString Technologies, Inc.
$12
Sirtex Medical Inc
$11
Biocartis US, Inc
$11
Veracyte, Inc.
$1
Top 3 companies account for 77.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALIYA SYSTEM · ALUNBRIG · Afstyla · Aimovig · Alecensa · BESREMI · BEVYXXA · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CINVANTI · COSELA · Certus 140 · DARZALEX · Da Vinci Surgical System · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Edwards SAPIEN 3 Transcatheter Heart Valve · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FEMARA · FOTIVDA · Fabhalta · Fusilev · GELCLAIR CONCENTRATED ORAL GEL · Gazyva · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Idylla · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · NURTEC ODT · Nplate · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · Perjeta · Polivy · Pomalyst · Prolia · REBLOZYL · RYBELSUS · RYBREVANT · Rezlidhia · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPECTRA WAVEWRITER · SUSTOL · Sifix · TAGRISSO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UPTRAVI · VENCLEXTA · VONJO · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for hematology in FL.
Equivalent to $19 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
8
Per 100K population
2.8
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 5%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 170,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $95,850 from 81 companies across 350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematologys in Gainesville?
Dr. Patel's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Gainesville
Browse hematologys in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc..
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology